This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (35)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Hypertension  • Neurology  • Dementias  • Alert me on articles by topic

The PROGRESS Collaborative Group*

Arch Intern Med. 2003;163:1069-1075.

Background  High blood pressure and stroke are associated with increased risks of dementia and cognitive impairment. This study aimed to determine whether blood pressure lowering would reduce the risks of dementia and cognitive decline among individuals with cerebrovascular disease.

Methods  The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) was a randomized, double-blind, placebo-controlled trial conducted among 6105 people with prior stroke or transient ischemic attack. Participants were assigned to either active treatment (perindopril for all participants and indapamide for those with neither an indication for nor a contraindication to a diuretic) or matching placebo(s). The primary outcomes for these analyses were dementia (using DSM-IV criteria) and cognitive decline (a decline of 3 or more points in the Mini-Mental State Examination score).

Results  During a mean follow-up of 3.9 years, dementia was documented in 193 (6.3%) of the 3051 randomized participants in the actively treated group and 217 (7.1%) of the 3054 randomized participants in the placebo group (relative risk reduction, 12% [95% confidence interval, -8% to 28%]; P = .2). Cognitive decline occurred in 9.1% of the actively treated group and 11.0% of the placebo group (risk reduction, 19% [95% confidence interval, 4% to 32%]; P = .01). The risks of the composite outcomes of dementia with recurrent stroke and of cognitive decline with recurrent stroke were reduced by 34% (95% confidence interval, 3% to 55%) (P = .03) and 45% (95% confidence interval, 21% to 61%) (P<.001), respectively, with no clear effect on either dementia or cognitive decline in the absence of recurrent stroke.

Conclusions  Active treatment was associated with reduced risks of dementia and cognitive decline associated with recurrent stroke. These findings further support the recommendation that blood pressure lowering with perindopril and indapamide therapy be considered for all patients with cerebrovascular disease.

*The writing committee for the PROGRESS Collaborative Group includes Christophe Tzourio, MD, PhD; Craig Anderson, MD, PhD; Neil Chapman, MD; Mark Woodward, PhD; Bruce Neal, MD, PhD; Stephen MacMahon, PhD; John Chalmers, MD, PhD. A complete listing of the members of the PROGRESS Collaborative Group was published previously (Lancet. 2001;385:1033-1041).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia
Chertkow et al.
CMAJ 2008;178:1273-1285.
ABSTRACT | FULL TEXT  

Validity of the Clinical Diagnostic Criteria for Vascular Dementia: A Critical Review. Part II
Wiederkehr et al.
J. Neuropsychiatry Clin. Neurosi. 2008;20:162-177.
ABSTRACT | FULL TEXT  

Prestroke Cognitive Function and Cerebrovascular Disease: If They Interact, It May Not Be Through Symptomatic Stroke
O'Sullivan
Stroke 2008;39:3-4.
FULL TEXT  

Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study
Verdelho et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:1325-1330.
ABSTRACT | FULL TEXT  

Cerebrovascular disease and dementia
KNOPMAN
Br. J. Radiol. 2007;80:S121-S127.
ABSTRACT | FULL TEXT  

Biomarkers of cerebrovascular disease in dementia
MILLS et al.
Br. J. Radiol. 2007;80:S128-S145.
ABSTRACT | FULL TEXT  

Modern concept of vascular cognitive impairment
Bowler
Br Med Bull 2007;83:291-305.
ABSTRACT | FULL TEXT  

Less Atherosclerosis and Lower Blood Pressure for a Meaningful Life Perspective With More Brain
Staessen et al.
Hypertension 2007;49:389-400.
FULL TEXT  

Maladie d'Alzheimer
Massoud
cfp 2007;53:50-54.
ABSTRACT | FULL TEXT  

Influence of Angiotensin-converting enzyme polymorphism on neuropsychological subacute performance in moderate and severe traumatic brain injury.
Ariza et al.
J. Neuropsychiatry Clin. Neurosi. 2006;18:39-44.
ABSTRACT | FULL TEXT  

When two are worse than one: Stroke and Alzheimer disease
DeCarli
Neurology 2006;67:1326-1327.
FULL TEXT  

Long-Term Cognitive Transitions, Rates of Cognitive Change, and Predictors of Incident Dementia in a Population-Based First-Ever Stroke Cohort
Srikanth et al.
Stroke 2006;37:2479-2483.
ABSTRACT | FULL TEXT  

Antihypertensive Medication Use and Incident Alzheimer Disease: The Cache County Study
Khachaturian et al.
Arch Neurol 2006;63:686-692.
ABSTRACT | FULL TEXT  

Reducing the Risk of Dementia: Efficacy of Long-Term Treatment of Hypertension
Peila et al.
Stroke 2006;37:1165-1170.
ABSTRACT | FULL TEXT  

White matter lesions and cognition: It's time for randomized trials to preserve intelligence
Hill and Mitchell
Neurology 2006;66:470-471.
FULL TEXT  

Constrictor and Dilator Effects of Angiotensin II on Cerebral Arterioles
Vincent et al.
Stroke 2005;36:2691-2695.
ABSTRACT | FULL TEXT  

Blood Pressure Lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and White Matter Hyperintensities: Should This Progress Matter to Patients?
Schiffrin
Circulation 2005;112:1525-1526.
FULL TEXT  

Blood Pressure Reduction for Vascular Risk: Is There a Price To Be Paid?
Birns et al.
Stroke 2005;36:1308-1313.
ABSTRACT | FULL TEXT  

Preventing dementia
Purandare et al.
Adv. Psychiatr. Treat. 2005;11:176-183.
ABSTRACT | FULL TEXT  

William M. Feinberg Lecture: Cognitive Vitality and the Role of Stroke and Cardiovascular Disease Risk Factors
Gorelick
Stroke 2005;36:875-879.
ABSTRACT | FULL TEXT  

Use of angiotensin-converting enzyme inhibitors and variations in cognitive performance among patients with heart failure
Zuccala et al.
Eur Heart J 2005;26:226-233.
ABSTRACT | FULL TEXT  

Antihypertensive Therapy Increases Cerebral Blood Flow and Carotid Distensibility in Hypertensive Elderly Subjects
Lipsitz et al.
Hypertension 2005;45:216-221.
ABSTRACT | FULL TEXT  

Midlife cardiovascular risk factors and risk of dementia in late life
Whitmer et al.
Neurology 2005;64:277-281.
ABSTRACT | FULL TEXT  

Progression of cognitive impairment in stroke patients
Sachdev et al.
Neurology 2004;63:1618-1623.
ABSTRACT | FULL TEXT  

The PROGRESS trial three years later: time for a balanced report of effectiveness
Wennberg and Zimmermann
BMJ 2004;329:968-970.
FULL TEXT  

October 12 Highlights and Commentary
Neurology 2004;63:1145-1145.
FULL TEXT  

Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI
Werring et al.
Brain 2004;127:2265-2275.
ABSTRACT | FULL TEXT  

Chronic Management of Blood Pressure After Stroke
Pedelty and Gorelick
Hypertension 2004;44:1-5.
FULL TEXT  

Preventing Dementia by Treating Hypertension and Preventing Stroke
Spence
Hypertension 2004;44:20-21.
FULL TEXT  

Emerging Therapies for Vascular Dementia and Vascular Cognitive Impairment
Erkinjuntti et al.
Stroke 2004;35:1010-1017.
ABSTRACT | FULL TEXT  

Vascular Cognitive Impairment
Bowler
Stroke 2004;35:386-388.
FULL TEXT  

Other articles noted
Evid. Based Med. 2004;9:31-32.
FULL TEXT  

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian et al.
Hypertension 2003;42:1206-1252.
ABSTRACT | FULL TEXT  

The ACE Gene I/D Polymorphism Is Not Associated With the Blood Pressure and Cardiovascular Benefits of ACE Inhibition
Harrap et al.
Hypertension 2003;42:297-303.
ABSTRACT | FULL TEXT  

Cerebral involvement in hypertensive cardiovascular disease
Coca
Eur Heart J Suppl 2003;5:F19-F25.
ABSTRACT